Skip to main content
Top
Published in: Journal of Cachexia, Sarcopenia and Muscle 3/2014

01-09-2014 | Editorial

An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada

Authors: Denis Guttridge, Marion Couch, Sergio Di Marco, Imed E. Gallouzi, Nancy D. Zitzmann, Vickie Baracos, Michael Rudnicki, Michel Tremblay, Teresa Zimmers

Published in: Journal of Cachexia, Sarcopenia and Muscle | Issue 3/2014

Login to get access

Excerpt

The National Cancer Institute in the USA has recently placed greater emphasis on cancer cachexia research by identifying this syndrome as a provocative question needing to be addressed in order to drive progress against cancer. Such funding mechanisms are expected to stimulate cutting edge approaches at both the basic and clinical science levels to advance our understanding of the underlying causes of cachexia. The goal is to identify and test lead compounds that preserve the loss of adipose and skeletal muscle tissues in pancreatic and other tumor types prone to developing cachexia. …
Metadata
Title
An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada
Authors
Denis Guttridge
Marion Couch
Sergio Di Marco
Imed E. Gallouzi
Nancy D. Zitzmann
Vickie Baracos
Michael Rudnicki
Michel Tremblay
Teresa Zimmers
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cachexia, Sarcopenia and Muscle / Issue 3/2014
Print ISSN: 2190-5991
Electronic ISSN: 2190-6009
DOI
https://doi.org/10.1007/s13539-014-0150-1

Other articles of this Issue 3/2014

Journal of Cachexia, Sarcopenia and Muscle 3/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.